May 23, 2016 — Endra Inc. announced that it has signed a global collaboration agreement with GE Healthcare to develop Endra's Thermo Acoustic Enhanced UltraSound (TAEUS).
The TAEUS technology is being developed to enable existing ultrasound systems to visualize tissue function and composition, and monitor a variety of therapeutic interventions at the point of care. Endra believes these capabilities could have broad potential clinical applications, including non-invasively quantifying fat in the liver for diagnosis of fatty liver disease, which affects over 1 billion globally.
Under the terms of the agreement, GE Healthcare will support Endra's efforts to commercialize the TAEUS technology for use in a fatty liver application by, among other things, providing equipment and technical advice, and facilitating introductions to GE Healthcare clinical ultrasound customers. In return for this assistance, Endra will afford GE Healthcare certain rights of first offer with respect to manufacturing and licensing rights for the target application.
For more information: www.endrainc.com
July 19, 2024 
